Document is current
Any future updates will be listed below
-
Authors
Savage, Paul https://orcid.org/0000-0003-2881-6717
Pacis, Alain
Kuasne, Hellen
Liu, Leah
Lai, Daniel https://orcid.org/0000-0001-9203-6323
Wan, Adrian
Dankner, Matthew
Martinez, Constanza
Muñoz-Ramos, Valentina https://orcid.org/0000-0002-2048-567X
Pilon, Virginie
Monast, Anie
Zhao, Hong
Souleimanova, Margarita
Annis, Matthew G. https://orcid.org/0000-0002-8776-004X
Aguilar-Mahecha, Adriana
Lafleur, Josiane
Bertos, Nicholas R.
Asselah, Jamil
Bouganim, Nathaniel
Petrecca, Kevin
Siegel, Peter M. https://orcid.org/0000-0002-5568-6586
Omeroglu, Atilla
Shah, Sohrab P. https://orcid.org/0000-0001-6402-523X
Aparicio, Samuel https://orcid.org/0000-0002-0487-9599
Basik, Mark
Meterissian, Sarkis
Park, Morag https://orcid.org/0000-0001-5400-606X
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research
EIF | Stand Up To Cancer
Réseau de Recherche en Cancer of the FRQS Québec Breast Cancer Foundation
- License Information
-
More Information
Article History
Received: 8 December 2019
Accepted: 26 May 2020
First Online: 16 June 2020
Competing interests
: S.A. is the cofounder and advisor to Contextual Genomics and scientific advisor to Sangamo Therapeutics, Chordia Therapeutics and Repare Therapeutics. All other authors declare no competing interests.
